CAITLIN JORDAN: Open Payments
NPI 1942562244 · CLEMSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,342 in 83 payments from 19 companies in 2025. Trend: 2023 $1,329 · 2024 $1,417 · 2025 $1,342
Food & beverage: $1,342
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $483 |
| PFIZER INC. | 11 | $157 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $111 |
| ARGENX US, INC. | 3 | $83 |
| Novo Nordisk Inc | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Alexion Pharmaceuticals, Inc. | 2 | $55 |
| Eisai Inc. | 2 | $54 |
| Lilly USA, LLC | 3 | $43 |
| Neurocrine BioSciences, Inc. | 2 | $41 |
Products named: UBRELVY, VRAYLAR, CAPLYTA, NURTEC ODT, VYVGART HYTRULO, REXULTI, ULTOMIRIS, Leqembi.
Industry payments across SC — which companies pay providers there.
